Sara Bystrup

626 total citations
8 papers, 459 citations indexed

About

Sara Bystrup is a scholar working on Molecular Biology, Oncology and Molecular Medicine. According to data from OpenAlex, Sara Bystrup has authored 8 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Molecular Medicine. Recurrent topics in Sara Bystrup's work include Retinoids in leukemia and cellular processes (2 papers), Curcumin's Biomedical Applications (2 papers) and Cancer-related Molecular Pathways (2 papers). Sara Bystrup is often cited by papers focused on Retinoids in leukemia and cellular processes (2 papers), Curcumin's Biomedical Applications (2 papers) and Cancer-related Molecular Pathways (2 papers). Sara Bystrup collaborates with scholars based in Spain, Denmark and United Kingdom. Sara Bystrup's co-authors include Eva Martinez‐Balibrea, José Luís Zamora Manzano, Laura Layos, Vicenç Ruiz de Porras, Albert Abad, Anna Martínez‐Cardús, Cristina Bugés, Alba Ginés, Manel Esteller and Cátia Moutinho and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Sara Bystrup

8 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Bystrup Spain	6	246	194	126	58	48	8	459
Chunjie Wen China	15	316 1.3×	105 0.5×	162 1.3×	35 0.6×	39 0.8×	29	519
Darko Castven Germany	10	229 0.9×	106 0.5×	114 0.9×	93 1.6×	43 0.9×	22	425
Mayrel Palestino Domínguez Mexico	9	201 0.8×	99 0.5×	81 0.6×	93 1.6×	36 0.8×	13	439
AmirReza Hesari Iran	13	315 1.3×	92 0.5×	163 1.3×	82 1.4×	31 0.6×	17	530
Rishi K. Gara India	12	323 1.3×	98 0.5×	84 0.7×	86 1.5×	40 0.8×	12	594
Siriporn Keeratichamroen Thailand	13	268 1.1×	119 0.6×	89 0.7×	26 0.4×	44 0.9×	23	492
Deblina Guha India	10	285 1.2×	182 0.9×	109 0.9×	38 0.7×	30 0.6×	16	497
Xiaomei Jiang China	9	215 0.9×	149 0.8×	154 1.2×	80 1.4×	53 1.1×	25	473
Zhan‐Qi Cao China	10	275 1.1×	112 0.6×	104 0.8×	34 0.6×	42 0.9×	14	528
Maike Priester Germany	5	269 1.1×	129 0.7×	111 0.9×	124 2.1×	55 1.1×	5	465

Countries citing papers authored by Sara Bystrup

Since Specialization

Citations

This map shows the geographic impact of Sara Bystrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Bystrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Bystrup more than expected).

Fields of papers citing papers by Sara Bystrup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Bystrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Bystrup. The network helps show where Sara Bystrup may publish in the future.

Co-authorship network of co-authors of Sara Bystrup

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Bystrup. A scholar is included among the top collaborators of Sara Bystrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Bystrup. Sara Bystrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Bernat‐Peguera, Adrià, et al.. (2022). Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data. The Breast. 62. 1–9. 3 indexed citations

Porras, Vicenç Ruiz de, Sara Bystrup, Eva Musulén, et al.. (2019). Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients. Cancers. 11(10). 1540–1540. 19 indexed citations

Porras, Vicenç Ruiz de, Sara Bystrup, Anna Martínez‐Cardús, et al.. (2016). Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway. Scientific Reports. 6(1). 24675–24675. 113 indexed citations

Martinez‐Balibrea, Eva, Anna Martínez‐Cardús, Alba Ginés, et al.. (2015). Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance. Molecular Cancer Therapeutics. 14(8). 1767–1776. 261 indexed citations

Ginés, Alba, Sara Bystrup, Vicenç Ruiz de Porras, et al.. (2015). PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines. PLoS ONE. 10(5). e0123830–e0123830. 32 indexed citations

Porras, Vicenç Ruiz de, Sara Bystrup, Anna Martínez‐Cardús, et al.. (2015). Abstract 5478: Curcumin mediates reversion to oxaliplatin-acquired resistance in colorectal cancer cell lines through modulation of nuclear factor κB (NFκB) and cyclin-dependent kinase 5 (CDK5). Cancer Research. 75(15_Supplement). 5478–5478. 3 indexed citations

Gregersen, Søren, et al.. (2013). Effects of Whey Proteins on Glucose Metabolism in Normal Wistar Rats and Zucker Diabetic Fatty (ZDF) Rats. The Review of Diabetic Studies. 10(4). 252–269. 10 indexed citations

Chen, Xiaoping, Kjeld Hermansen, Jianzhong Xiao, et al.. (2012). Isosteviol Has Beneficial Effects on Palmitate-Induced α-Cell Dysfunction and Gene Expression. PLoS ONE. 7(3). e34361–e34361. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact